Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Kisqali
Pharma
Novartis pressures Lilly with Kisqali's broad breast cancer nod
The expanded label separates Novartis' Kisqali from Eli Lilly's Verzenio by covering patients who don't have cancer cells in their lymph nodes.
Angus Liu
Sep 17, 2024 3:04pm
Novartis CEO sees IRA impact ‘manageable’ in short run
Jul 18, 2024 11:05am
Novartis gears up for key expansions of 3 cancer drugs
Apr 23, 2024 3:37pm
Novartis halts recruitment of trials for cancer drug Kisqali
Apr 10, 2024 11:09am
FDA chides Novartis for ‘false or misleading’ Kisqali TV spot
Jan 23, 2024 8:46am
SABCS: Novartis gives update on Kisqali in early breast cancer
Dec 8, 2023 9:15am
